Pharmaceutical contract packaging organisation Tjoapack is expanding in the USA with the opening of a new 170,000 ft2 facility next to its existing site in Clinton, Tennessee.
The new facility features GMP packaging, labelling, cold chain and ambient storage capabilities to accommodate rising client demand. It is scheduled for completion in early 2027.
Tjoapack said the expansion reflects its ongoing commitment to investing in infrastructure that enhances service flexibility and addresses growing client demand across the pharmaceutical supply chain.
Scheduled for completion in early 2027, the new building will support new high-speed packaging lines for bottles and blisters, injectable products and various secondary packaging configurations.
“This expansion marks a major step in our strategic goal to enhance our presence in the United States. As a crucial market with considerable growth opportunities, it allows us to serve our existing clients more effectively and attract new ones,” stated Dexter Tjoa, CEO of Tjoapack.
“We’ve invested heavily in automating our core processes, not only within packaging lines but throughout our cross-company workflows with customers and material vendors. This allows us to reduce human error and enhance accuracy, speed, and flexibility, which ultimately benefits our clients.”
The North America pharmaceutical contract packaging market was valued at US$9.5bn (£7.1bn) in 2024 and projected to reach US$17.8bn (£13.3bn) by 2033, IMARC Group estimates.
IntraLogisteX
is moving to Dallas in 2026, bringing the industry’s leading trade show & conference to one of North America’s most important logistics hubs. The event creates a focused environment for supply chain and manufacturing professionals to share ideas, discover solutions, and drive greater efficiency, agility, scalability, and accuracy.
